Literature DB >> 22180367

Delta opioid receptors contribute to the cardiorespiratory effects of biphalin in anesthetized rats.

Piotr Wojciechowski1, Małgorzata Szereda-Przestaszewska, Andrzej W Lipkowski.   

Abstract

Biphalin expresses almost equal affinity for μ- and δ-opioid receptors. The aim of this study was to delineate a possible role of δ-opioid receptors in the cardio-respiratory effects of systemic injection of biphalin in anesthetized, spontaneously breathing rats. In control animals, an intravenous bolus of biphalin (0.3 μmol/kg) evoked apnea, followed by a decreased breathing rate and increased tidal volume, hypotension and bradycardia. Blockade of δ-opioid receptors with naltrindole (4.2 μmol/kg) significantly reduced the duration of apnea, slowdown of respiration, immediate post-challenge hypotension and bradycardia induced by biphalin administration. These results indicate that the activation of δ-opioid receptors adds to the depressive response produced by biphalin.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22180367     DOI: 10.1016/s1734-1140(11)70644-2

Source DB:  PubMed          Journal:  Pharmacol Rep        ISSN: 1734-1140            Impact factor:   3.024


  2 in total

1.  Behavioral pharmacology of the mixed-action delta-selective opioid receptor agonist BBI-11008: studies on acute, inflammatory and neuropathic pain, respiration, and drug self-administration.

Authors:  Glenn W Stevenson; Denise Giuvelis; James Cormier; Katherine Cone; Phillip Atherton; Rebecca Krivitsky; Emily Warner; Brooke St Laurent; Julio Dutra; Jean M Bidlack; Lajos Szabò; Robin Polt; Edward J Bilsky
Journal:  Psychopharmacology (Berl)       Date:  2020-01-07       Impact factor: 4.530

Review 2.  Biphalin-A Potent Opioid Agonist-As a Panacea for Opioid System-Dependent Pathophysiological Diseases?

Authors:  Patrycja Redkiewicz; Jolanta Dyniewicz; Aleksandra Misicka
Journal:  Int J Mol Sci       Date:  2021-10-21       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.